Collagen metabolites in the prediction of response to GH therapy in short children

European Journal of Endocrinology

Volumn 137, Issue 6, 1997, Pages 621-625

  Tapanainen, P ^a   Knip, M ^a   Risteli, L ^a   Kemppainen, L ^a   Kaar M L ^b   Risteli, J ^a  

^a UNIVERSITY OF OULU   (Finland)

^b VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; PROCOLLAGEN; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BONE AGE; CHILD; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE DEFICIENCY; HEIGHT; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; BONE DEVELOPMENT; CHILD; CHILD, PRESCHOOL; COLLAGEN; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INFANT; PEPTIDE FRAGMENTS; RADIOIMMUNOASSAY;

EID: 0031451608     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1370621     Document Type: Article

References (18)

1. Albertsson-Wikland K & Hall K. Growth hormone treatment in short children: relationship between growth and serum insulin-like growth factor I and II levels. Journal of Clinical Endocrinology and Metabolism 1987 65 671-678.
2. Rosenfeld RP, Kemp SF & Hintz RL. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism and lack of correlation with growth rate. Journal of Clinical Endocrinology and Metabolism 1981 53 611-617.
3. Hintz R, Frane J, Sherman B & The Genentech Collaborative group. Pretreatment IGF-I correlate with growth response to GH in hypopituitarism: the importance of acid separation. Pediatric Research 1988 24 522.
4. Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AP & Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clinical Chemistry 1988 34 715-718.
5. Tapanainen P, Risteli L, Knip M, Käär M-L & Risteli J. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy. Journal of Clinical Endocrinology and Metabolism 1989 67 1244-1249.
6. Trivedi P, Hindmarsh P, Risteli J, Risteli L, Mowat AP & Brook CGD. Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen. Journal of Pediatrics 1989 114 225-230.
7. Danne T, Gruters A, Schuppan D, Quantas N, Enders I & Weber B. Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders. Journal of Pediatrics 1989 114 257-260.
8. Carey DE, Goldberg B, Ratzan S, Rubin KR & Rowe DW. Radioimmunoassay for type I procollagen in growth hormone-deficient children before and during treatment with growth hormone. Pediatric Research 1985 19 8-11.
9. Saggese G, Baroncelli I, Bertelloni S, Cinquanta L & Di Nero G. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, aminoterminal propeptide of type in procollagen rhythms in normal and growth-retarded children. Pediatric Research 1994 35 409-415.
10. Trivedi P, Risteli J, Risteli L, Hindmarsh P, Brook CGD & Mowat AP. Serum concentrations of the type I and III procollagen peptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatric Research 1991 30 276-280.
11. Sorva R, Perheentupa J & Tolppanen EM. A novel format for a growth chart. Acta Pediatricia Scandinavica 1984 73 527-529.
12. Tanner JM & Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity and stages of puberty. Archives of Diseases in Childhood 1976 51 170-179.
13. Greulich WW & Pyle SL. Radiographic Atlas of Skeletal Development of the Hand and the Wrist, edn 2, pp 256. Stanford, CA: Stanford University Press, 1959.
14. Melkko J, Niemi S, Risteli L & Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clinical Chemistry 1990 36 1328-1332.
15. Risteli L & Risteli J. Biochemical markers of bone metabolism. Annals of Medicine 1993 25 3859-393.
16. Eriksen EF, Brixen K & Charles P. New markers of bone metabolism: clinical use in metabolic bone disease. European Journal of Endocrinology 1995 132 251-263.
17. Jensen LT, Jorgensen JOL, Risteli J, Christiansen JS & Lorenzen I. Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GH. Acta Endocrinologica 1991 124 278-282.
18. Melkko J, Kauppila S, Niemi S, Risteli L, Haukipuro K, Jukkola A & Risteli J. Immmunoassay for intact amino-terminal propeptide of human type I procollagen. Clinical Chemistry 1996 42 947-954.